R Gray

Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer.

R. Gray, D. Tormey, J. Arseneau, 1986, NCI monographs : a publication of the National Cancer Institute.

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.

C K Osborne, R. Gray, C. Osborne, 1989, The New England journal of medicine.

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.

H Volk, R. Gray, J. Bennett, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genotypic characterization of phenotypically defined triple-negative breast cancer.

S Badve, G W Sledge, R Gray, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.

J F Simpson, R. Gray, N. Robert, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.

R. Gray, D. Tormey, J. Arseneau, 1985, Annals of internal medicine.